RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Craniopharyngioma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Corrigendum to "Chinese guidelines for the diagnosis and treatment of Craniopharyngioma in children (2025)" [Cancer Lett. 659 (2026) 218784].
Lin Zhixiong et al., Cancer letters (17 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42892606/
- 2.
[Patients with papillary craniopharyngioma successfully treated with BRAF and MEK inhibitors].
Marie Erfurth Eva et al., Lakartidningen (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42885245/
- 3.
Neoadjuvant Treatment of BRAFV600E Papillary Craniopharyngiomas: A Case Series.
Wang Amy J et al., Operative neurosurgery (Hagerstown, Md.) (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42872864/
- 4.
Chopsticks mononostril endoscopic endonasal approach for adult Craniopharyngioma: A retrospective comparative cohort study.
Deng Xuehai et al., Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42874422/
- 5.
Douglas W. C. Northfield (1902-1976): his crucial contribution to safer craniopharyngioma surgery.
Prieto Ruth et al., Journal of neurosurgery (9 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42854243/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
NCT05919264 · Recruiting · Phase 1 / Phase 2 · Parabilis Medicines, Inc.
Ages 18 and over
https://clinicaltrials.gov/study/NCT05919264
- 2.
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
NCT05286788 · Recruiting · Phase 2 · Nationwide Children's Hospital
Ages 1 to 39
https://clinicaltrials.gov/study/NCT05286788
- 3.
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
NCT05233397 · Recruiting · Phase 2 · Nationwide Children's Hospital
Ages 1 to 39
https://clinicaltrials.gov/study/NCT05233397
- 4.
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
NCT05465174 · Recruiting · Phase 2 · Sabine Mueller, MD, PhD
Ages 1 to 39
https://clinicaltrials.gov/study/NCT05465174
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Craniopharyngioma
Craniopharyngioma is a rare, non-cancerous brain tumour that grows near the pituitary gland and the base of the brain. It can affect vision, hormone production, growth and appetite. It occurs in children and in adults. Treatment usually involves surgery, radiotherapy or both, and long-term hormone replacement and monitoring are often needed.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Craniopharyngioma?
Craniopharyngioma is a rare, non-cancerous brain tumour that grows near the pituitary gland and the base of the brain. It can affect vision, hormone production, growth and appetite. It occurs in children and in adults. Treatment usually involves surgery, radiotherapy or both, and long-term hormone replacement and monitoring are often needed.
How many clinical trials are available for Craniopharyngioma?
RareWays currently indexes 48 clinical trials for Craniopharyngioma, of which 8 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Craniopharyngioma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Craniopharyngioma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.